These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18824609)

  • 1. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility.
    Breidenstein EB; Khaira BK; Wiegand I; Overhage J; Hancock RE
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4486-91. PubMed ID: 18824609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.
    Brazas MD; Breidenstein EB; Overhage J; Hancock RE
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4276-83. PubMed ID: 17893152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fis Contributes to Resistance of Pseudomonas aeruginosa to Ciprofloxacin by Regulating Pyocin Synthesis.
    Long Y; Fu W; Wang S; Deng X; Jin Y; Bai F; Cheng Z; Wu W
    J Bacteriol; 2020 May; 202(11):. PubMed ID: 32205461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa.
    Zhao L; Wang S; Li X; He X; Jian L
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):124. PubMed ID: 32758289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of nfuA enhances susceptibility of Pseudomonas aeruginosa to fluoroquinolone antibiotics.
    Daung-nkern J; Vattanaviboon P; Mongkolsuk S
    J Antimicrob Chemother; 2010 Aug; 65(8):1831-2. PubMed ID: 20525732
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacterial antibiotic resistance studies using in vitro dynamic models: Population analysis vs. susceptibility testing as endpoints of mutant enrichment.
    Firsov AA; Strukova EN; Portnoy YA; Shlykova DS; Zinner SH
    Int J Antimicrob Agents; 2015 Sep; 46(3):313-8. PubMed ID: 26297633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
    Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
    Muramatsu H; Horii T; Takeshita A; Hashimoto H; Maekawa M
    Chemotherapy; 2005 May; 51(2-3):70-5. PubMed ID: 15870499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
    Pankey GA; Ashcraft DS
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV; Ballal M; Shivananda PG
    Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P; Hocquet D; Jeannot K; Chavanet P; Plésiat P
    J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa deficient in 8-oxodeoxyguanine repair system shows a high frequency of resistance to ciprofloxacin.
    Morero NR; Argaraña CE
    FEMS Microbiol Lett; 2009 Jan; 290(2):217-26. PubMed ID: 19025574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
    Hansen GT; Zhao X; Drlica K; Blondeau JM
    Int J Antimicrob Agents; 2006 Feb; 27(2):120-4. PubMed ID: 16426820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa.
    Brazas MD; Hancock RE
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3222-7. PubMed ID: 16048929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
    Strukova EN; Portnoy YA; Zinner SH; Firsov AA
    J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.
    Pasca MR; Dalla Valle C; De Jesus Lopes Ribeiro AL; Buroni S; Papaleo MC; Bazzini S; Udine C; Incandela ML; Daffara S; Fani R; Riccardi G; Marone P
    Microb Drug Resist; 2012 Feb; 18(1):23-32. PubMed ID: 21797666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.